Latest Healthcare Research Reports

Tag: pharma admet testing market analysis

  • Pharma ADMET Testing Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

    Pharma ADMET Testing Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Is The Expected Market Size Of The Pharma ADMET Testing Market From 2026 To 2030?

    The pharma admet testing market has demonstrated substantial expansion in recent years. This market is anticipated to expand from $10.7 billion in 2025 to $11.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.1%. Historically, the market’s growth can be attributed to several factors such as increasing pharmaceutical research and development investments, the broadening scope of preclinical drug testing requirements, the escalating complexity of drug molecules, a stronger regulatory focus on safety profiling, and the accessibility of advanced laboratory technologies.

    The market for pharma admet testing is projected to expand significantly over the coming years. This market is set to reach a value of $19.27 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.6%. Key factors driving this expansion during the forecast period include a heightened demand for cost-effective drug development, the growing embrace of predictive admet analytics, the broadening scope of personalized medicine pipelines, the increasing incorporation of machine learning into drug testing processes, and a rise in the outsourcing of admet testing services. Notable trends anticipated during this period encompass the greater uptake of in silico admet modeling tools, an expanding utilization of high-throughput screening technologies, the development of AI-based toxicity prediction platforms, increased integration of omics data within drug testing, and a stronger emphasis on assessing drug safety in early development stages.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

    What Drivers Are Influencing The Pharma ADMET Testing Market?

    An expanding volume of clinical trials is anticipated to fuel the expansion of the pharma ADMET testing market in the future. A clinical trial represents a research endeavor involving human subjects, aimed at assessing the safety, effectiveness, and possible adverse reactions of a medical intervention, which could include a novel drug, medical apparatus, diagnostic method, or therapeutic approach. This surge in clinical trials significantly heightens the requirement for comprehensive drug safety and efficacy evaluations within the pharma ADMET testing market, highlighting the crucial necessity for specific assessments across various drug candidates and patient groups. As an illustration, in December 2024, data from the Association of the British Pharmaceutical Industry, a nonprofit organization based in the UK, indicated that industry-initiated clinical trials in the UK rose from 411 trials in 2022 to 426 trials in 2023, representing a 3.7% increase. Consequently, the rising count of clinical trials is a primary factor propelling the expansion of the pharma ADMET testing market.

    Which Segments Are Included In The Analysis Of The Pharma ADMET Testing Market?

    The pharma admet testing market covered in this report is segmented –

    1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing

    2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology

    3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

    Subsegments:

    1) By In Vivo ADMET Testing: Animal Studies, Pharmacokinetics Studies, Toxicology Studies, Biodistribution Studies

    2) By In Vitro ADMET Testing: Metabolism Studies, Drug-Drug Interaction Studies, Absorption Studies, Cytotoxicity And Safety Testing

    3) By In Silico ADMET Testing: Predictive Modeling and Simulation, Quantitative Structure-Activity Relationship (QSAR) Analysis, Machine Learning Algorithms For ADMET Predictions, Software Tools For ADMET Profiling

    What Trends Are Affecting The Expansion Of The Pharma ADMET Testing Market?

    Leading companies in the pharma ADMET testing market are introducing innovative products like artificial intelligence-driven drug design, which enables the automated de novo generation of novel small molecule structures. Artificial intelligence-driven drug design refers to utilizing artificial intelligence (AI) to design and optimize drug molecules without solely relying on traditional lab-based screening or manual medicinal chemistry. For instance, in June 2025, Simulations Plus Inc., a US-based company specializing in cheminformatics software for the pharmaceutical sector, launched ADMET Predictor 13. This platform is an advanced artificial intelligence-driven drug-design and ADMET-prediction tool, integrating enhanced high-throughput PBPK simulations and a generative AI-enabled drug-design engine (AIDD). Additionally, it offers streamlined workflows, allowing for faster and more informed decision-making in drug development.

    Which Key Industry Participants Are Active In The Pharma ADMET Testing Market?

    Major companies operating in the pharma admet testing market are Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.

    Read the full pharma admet testing market report here:

    https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

    Which Regions Are Expected To Experience Rapid Expansion In The Pharma ADMET Testing Market?

    Asia-Pacific was the largest region in the pharma ADMET testing market in 2025. The regions covered in the pharma admet testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Pharma ADMET Testing Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=12024&type=smp

    Browse Through More Reports Similar to the Global Pharma ADMET Testing Market 2026, By The Business Research Company

    Pet Fitness Care Global Market Report

    https://www.thebusinessresearchcompany.com/report/pet-fitness-care-global-market-report

    Pet Diabetes Care Global Market Report

    https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

    Pet Food Global Market Report

    https://www.thebusinessresearchcompany.com/report/pet-food-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Pharma ADMET Testing Market Set for Strong Expansion, Reaching $19.27 Billion With 12.6% CAGR by 2030

    Global Pharma ADMET Testing Market Set for Strong Expansion, Reaching $19.27 Billion With 12.6% CAGR by 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the pharma admet testing market from 2026–2035 with trusted insights from The Business Research Company

    What total market size is anticipated for the Pharma ADMET Testing Market in 2030?

    The pharma admet testing market size has experienced substantial expansion in recent years. It is anticipated to increase from $10.7 billion in 2025 to $11.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.1%. The upward trend observed historically can be attributed to various elements, including escalating pharmaceutical r&d investments, the broadening requirements for preclinical drug testing, the increasing complexity of drug molecules, a heightened regulatory emphasis on safety profiling, and the availability of advanced laboratory technologies.

    The pharma admet testing market is poised for significant expansion in the coming years. It is projected to reach $19.27 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.6%. This growth throughout the forecast period is driven by factors such as the escalating demand for cost-efficient drug development, the increasing adoption of predictive ADMET analytics, the expansion of personalized medicine pipelines, the growing integration of machine learning in drug testing, and a rise in the outsourcing of ADMET testing services. Major trends anticipated during this period include a broader uptake of in silico ADMET modeling tools, an increased utilization of high-throughput screening technologies, the development of AI-based toxicity prediction platforms, a greater incorporation of omics data in drug testing, and a sharpened focus on early-stage drug safety evaluation.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

    What Drivers Are Influencing Production Trends In The Pharma ADMET Testing Market?

    An anticipated rise in the number of clinical trials is projected to propel the expansion of the pharma ADMET testing market in the future. A clinical trial represents a scientific investigation involving human subjects, primarily aimed at assessing the safety, effectiveness, and possible adverse reactions of a medical intervention, including novel drugs, medical devices, diagnostic methods, or therapeutic approaches. This surge in clinical trials significantly heightens the requirement for comprehensive evaluations of drug safety and efficacy within the pharma ADMET testing market, underscoring the vital importance of customized assessments for various drug candidates and patient demographics. For instance, data from December 2024, as reported by the Association of the British Pharmaceutical Industry, a UK-based nonprofit organization, indicated that industry-initiated clinical trials in the UK expanded from 411 trials in 2022 to 426 trials in 2023, which constitutes a 3.7% increase. Consequently, the observed growth in clinical trials is a primary driver for the development of the pharma ADMET testing market.

    Which Segment Groups Are Influencing The Pharma ADMET Testing Market?

    The pharma admet testing market covered in this report is segmented –

    1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing

    2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology

    3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

    Subsegments:

    1) By In Vivo ADMET Testing: Animal Studies, Pharmacokinetics Studies, Toxicology Studies, Biodistribution Studies

    2) By In Vitro ADMET Testing: Metabolism Studies, Drug-Drug Interaction Studies, Absorption Studies, Cytotoxicity And Safety Testing

    3) By In Silico ADMET Testing: Predictive Modeling and Simulation, Quantitative Structure-Activity Relationship (QSAR) Analysis, Machine Learning Algorithms For ADMET Predictions, Software Tools For ADMET Profiling

    Which Trends Are Guiding The Evolution Of The Pharma ADMET Testing Market?

    Leading companies in the pharma ADMET testing market are bringing in innovative products, including artificial intelligence-driven drug design, which allows for the automated creation of novel small molecule structures from the ground up. Artificial intelligence-driven drug design refers to the application of artificial intelligence (AI) to design and optimize drug molecules without relying exclusively on traditional lab-based screening or manual medicinal chemistry. For example, in June 2025, Simulations Plus Inc., a US-based firm specializing in cheminformatics software for the pharmaceutical sector, launched ADMET Predictor 13. This is an advanced artificial intelligence-driven platform for drug design and ADMET prediction, which integrates enhanced high-throughput PBPK simulations and a generative AI-enabled drug-design engine (AIDD). Additionally, it offers optimized workflows that enable faster and more informed decision-making in drug development.

    Who Are The Core Companies Influencing Trends In The Pharma ADMET Testing Market?

    Major companies operating in the pharma admet testing market are Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

    Which Regions Are Projected To Dominate The Pharma ADMET Testing Market In The Coming Years?

    Asia-Pacific was the largest region in the pharma ADMET testing market in 2025. The regions covered in the pharma admet testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Pharma ADMET Testing Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=12024&type=smp

    Browse Through More Reports Similar to the Global Pharma ADMET Testing Market 2026, By The Business Research Company

    Software Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/software-testing-global-market-report

    Adme Toxicology Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

    Testing Software Market Report 2026

    https://www.thebusinessresearchcompany.com/report/testing-software-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • What Is The Long-Term Forecast For The Global Pharma ADMET Testing Market Growing At 12.3% CAGR?

    What Is The Long-Term Forecast For The Global Pharma ADMET Testing Market Growing At 12.3% CAGR?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What CAGR And Valuation Are Anticipated For The Pharma ADMET Testing Market?

    The market size of pharma admet testing has experienced a swift expansion in the past few years. Predictions show that it will rise from a value of $9.67 billion in 2024 to an impressive $10.7 billion in 2025 with a compound annual growth rate (CAGR) of 10.6%. Factors contributing to this growth in the historic period include an increase in biopharmaceuticals and biosimilars, elevated activities in drug development, a surge in awareness about drug safety, the global expansion of clinical trials, and a transition towards in silico modeling.

    Expectations are high for the pharma admet testing market as it is set on a path of swift expansion in the coming years. Forecasts project it to escalate to a market size of $17.03 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.3%. Contributing factors for this growth during the forecast period can be traced to environmental toxicology and safety assessment, a heightened awareness of pharmacogenomics, a shift towards precision medicine, an upsurge in biologics and biosimilars, the incorporation of artificial intelligence (AI), augmented regulatory mandates, and a surge in orphan drug development. The forecast period also reveals several emerging trends including the upscaling of research collaborations, swift progress in technology, advances in analytical technologies, perpetual monitoring of drug safety, and consideration of environmental impacts.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

    What Are The Primary Factors Supporting The Pharma ADMET Testing Market Expansion?

    The increase in product approval numbers is propelling the pharmaceutical ADMET testing market forward. This pertains to the procedures carried out by regulatory bodies like the United States’ Food and Drug Administration (FDA) or Europe’s European Medicines Agency (EMA), which provide clearance for a product to be sold and marketed to consumers. ADMET testing plays a critical role in assessing the safety and effectiveness of new products and is a compulsory requirement in attaining product regulatory clearances. For instance, figures from the National Library of Medicine, a US-based biomedical information resource for healthcare professionals, showed that there were 55 new drugs given the green light by the FDA in 2023, a significant increase from the 37 approved in 2022. Consequently, this heightened rate of product approvals fuels the growth of the pharmaceutical ADMET testing market.

    Which Segments Define The Structure Of The Pharma ADMET Testing Market?

    The pharma admet testingmarket covered in this report is segmented –

    1) By Testing Type: In Vivo ADMET Testing; In Vitro ADMET Testing; In Silico ADMET Testing

    2) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology

    3) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications

    Subsegments:

    1) By In Vivo ADMET Testing: Animal Studies; Pharmacokinetics Studies; Toxicology Studies; Biodistribution Studies

    2) By In Vitro ADMET Testing: Metabolism Studies; Drug-Drug Interaction Studies; Absorption Studies; Cytotoxicity and Safety Testing

    3) By In Silico ADMET Testing: Predictive Modeling and Simulation; Quantitative Structure-Activity Relationship (QSAR) Analysis; Machine Learning Algorithms for ADMET Predictions; Software Tools for ADMET Profiling

    What Strategic Shifts And Innovations Are Influencing The Pharma ADMET Testing Market?

    Product innovation is emerging as a pivotal trend in the pharmaceutical ADMET testing market, with leading companies launching groundbreaking products to consolidate their market standing. For instance, Logica, a pioneering AI-driven drug development solution, was launched in April 2022 by Charles River Laboratories International Inc., an American pharmaceutical firm, and Valo Health Inc., a US-based AI-health solution provider. The novel product harnesses the power of Valo’s AI-enabled Opal Computational Platform to render ADMET testing services and various drug delivery solutions. Logica employs top-tier predictive models, chemical synthesis and design, DNA coded libraries, and in silico high throughput screening from Valo’s Opal Computational Platform. It also capitalizes on Charles River’s top-notch abilities in every facet of discovery optimization, including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, and safety testing, culminating in IND submission.

    Who Are The Primary Market Leaders In The Pharma ADMET Testing Market?

    Major companies operating in the pharma ADMET testing market include Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

    What Regional Factors Are Accelerating Growth In The Pharma ADMET Testing Market?

    Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=12024&type=smp

    Browse Through More Reports Similar to the Global Pharma ADMET Testing Market 2025, By The Business Research Company

    Healthcare Analytical Testing Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/healthcare-analytical-testing-services-global-market-report

    Automotive Testing Inspection And Certification Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/automotive-testing-inspection-and-certification-global-market-report

    Cold Plasma Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Pharma ADMET Testing Market Trends and Growth Analysis 2025–2029

    Global Pharma ADMET Testing Market Trends and Growth Analysis 2025–2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    By How Much Is The Pharma ADMET Testing Market Expected To Expand Between 2025 And 2029?

    The market size for pharma admet testing has experienced rapid growth in recent years. It is projected to increase from $9.67 billion in 2024 to $10.7 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.6%. The expansion observed in the historical period can be ascribed to factors such as the rise of biopharmaceuticals and biosimilars, an uptick in drug development activities, increasing consciousness about drug safety, the worldwide spread of clinical trials, and a move towards in silico modeling.

    The market for pharma admet testing is projected to expand significantly over the coming years. Its valuation is anticipated to reach $17.03 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.3%. This expansion during the forecast period stems from factors such as environmental toxicology and safety assessments, heightened awareness of pharmacogenomics, a strong emphasis on precision medicine, the proliferation of biologics and biosimilars, the incorporation of artificial intelligence (AI), stricter regulatory mandates, and an increase in the development of orphan drugs. Key trends for this period encompass greater research collaborations, swift technological breakthroughs, enhancements in analytical methodologies, ongoing oversight of drug safety, and growing attention to environmental impact.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

    Which Drivers Are Impacting The Pharma ADMET Testing Market?

    An increasing number of product authorizations is propelling the pharma ADMET testing market. These product approvals denote the procedure through which regulatory bodies, such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe, grant permission for a product to be marketed and sold to the public. ADMET testing is vital for determining the safety and efficacy of novel products and is a mandatory component of product regulatory approvals. For instance, in January 2024, the National Library of Medicine, a US-based biomedical library and a national resource for health professionals, reported that the U.S. Food and Drug Administration (FDA) sanctioned 55 new drugs in 2023, marking an increase from 37 drugs approved in 2022. Consequently, the escalating volume of product approvals fuels the pharma ADMET testing market.

    What Are The Leading Segments Analyzed In The Pharma ADMET Testing Market?

    The pharma admet testingmarket covered in this report is segmented –

    1) By Testing Type: In Vivo ADMET Testing; In Vitro ADMET Testing; In Silico ADMET Testing

    2) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology

    3) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications

    Subsegments:

    1) By In Vivo ADMET Testing: Animal Studies; Pharmacokinetics Studies; Toxicology Studies; Biodistribution Studies

    2) By In Vitro ADMET Testing: Metabolism Studies; Drug-Drug Interaction Studies; Absorption Studies; Cytotoxicity and Safety Testing

    3) By In Silico ADMET Testing: Predictive Modeling and Simulation; Quantitative Structure-Activity Relationship (QSAR) Analysis; Machine Learning Algorithms for ADMET Predictions; Software Tools for ADMET Profiling

    Which Market Trends Are Creating New Opportunities In The Pharma ADMET Testing Industry?

    Product innovations represent a significant trend gaining traction within the pharma ADMET testing market. Major companies in this market segment are actively launching advanced products, such as Logica, to secure their competitive standing. For example, in April 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company, collaborated with Valo Health Inc., a US-based AI-health solution provider, to introduce Logica, an AI-driven solution for drug development. This innovative solution harnesses Valo’s AI-powered Opal Computational Platform to deliver ADMET testing services and other drug delivery capabilities to users. Logica incorporates premier predictive models, chemical design and synthesis capabilities, DNA encoded libraries, and in silico high throughput screening from Valo’s Opal Computational Platform, complemented by Charles River’s extensive expertise in every facet of discovery optimization, including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, and ultimately safety testing and IND submission.

    Who Are The Key Multinational Companies Dominating The Pharma ADMET Testing Market?

    Major companies operating in the pharma ADMET testing market include Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

    How Is Pharma ADMET Testing Market Demand Varying Across Different Regions?

    Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Pharma ADMET Testing Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=12024&type=smp

    Browse Through More Reports Similar to the Global Pharma ADMET Testing Market 2025, By The Business Research Company

    Healthcare Analytical Testing Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/healthcare-analytical-testing-services-global-market-report

    Automotive Testing Inspection And Certification Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/automotive-testing-inspection-and-certification-global-market-report

    Cold Plasma Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Pharma ADMET Testing Market Trends: Regional Breakdowns and Strategic Insights

    Global Pharma ADMET Testing Market Trends: Regional Breakdowns and Strategic Insights

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has The Pharma ADMET Testing Market Growth Evolved From 2024 To 2025, And What’s Ahead?

    The market size for pharma admet testing has seen a swift expansion in the past few years. An anticipated growth from $9.67 billion in 2024 to $10.7 billion in 2025 denotes a compound annual growth rate (CAGR) of 10.6%. Factors that contributed to the market growth in the historical period include increasing drug development activities, enhancing awareness about drug safety, escalating biopharmaceuticals and biosimilars, expanding clinical trial globalization and a shift towards in silico modeling.

    Rapid expansion is anticipated for the pharma admet testing market size in the forthcoming years, with projections indicating it will escalate to $17.03 billion by 2029, posting a compound annual growth rate (CAGR) of 12.3%. This growth during the projected period can be credited to various factors such as environmental toxicology, safety assessment, cognizance towards pharmacogenomics, emphasis on precision medicine, ascendancy of biologics and biosimilars, incorporation of artificial intelligence (AI), broadened regulatory stipulations, and the surge in orphan drug development. Notable trend shifts expected during this period encompass an increase in research collaborations, speedy advances in technology, analytical technology enhancements, unceasing surveillance of drug safety, and considerations of environmental impact.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

    What Are the Major Market Drivers Behind the Rising Adoption of Pharma ADMET Testing Market?

    The increase in the number of product approvals is fuelling the growth of the pharma ADMET testing market. The term ‘product approvals’ refers to the authorization process undertaken by regulatory bodies such as the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA) in Europe, which allows a product to be sold and promoted to consumers. ADMET testing, which is requisite for product regulatory approvals, is instrumental in evaluating the safety and effectiveness of new products. For example, the National Library of Medicine, a US-based biomedical library and health professional resource, reported that there were 55 new FDA-approved drugs in January 2024, an increase from the 37 drugs that were approved in 2022. Consequently, the escalating trend in product approvals is propelling the pharma ADMET testing market.

    Which Key Market Segments Comprise the Pharma ADMET Testing Market and Drive Its Revenue Growth?

    The pharma admet testingmarket covered in this report is segmented –

    1) By Testing Type: In Vivo ADMET Testing; In Vitro ADMET Testing; In Silico ADMET Testing

    2) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology

    3) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications

    Subsegments:

    1) By In Vivo ADMET Testing: Animal Studies; Pharmacokinetics Studies; Toxicology Studies; Biodistribution Studies

    2) By In Vitro ADMET Testing: Metabolism Studies; Drug-Drug Interaction Studies; Absorption Studies; Cytotoxicity and Safety Testing

    3) By In Silico ADMET Testing: Predictive Modeling and Simulation; Quantitative Structure-Activity Relationship (QSAR) Analysis; Machine Learning Algorithms for ADMET Predictions; Software Tools for ADMET Profiling

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=12024&type=smp

    Which Areas Are Leading Regions in the Pharma ADMET Testing Market Expansion Across the Globe?

    Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Strategic Trends Steering thePharma ADMET Testing Market Direction?

    A significant trend emerging in the pharma ADMET testing market is product innovation. Leading companies in this market, are launching ground-breaking products such as Logica to retain their market dominance. In April 2022, for example, Charles River Laboratories International Inc, a pharmaceutical firm based in the US, and Valo Health Inc, a provider of AI-health solutions also based in the US, introduced Logica, a solution for AI-driven drug development. This new solution utilizes Valo’s AI-enabled Opal Computational Platform to offer ADMET testing services along with other drug delivery solutions. Logica employs premier predictive models, chemical design and synthesis capabilities, DNA encoded libraries, and in silico high throughput screening from Valo’s Opal Computational Platform. This, combined with Charles River’s unparalleled expertise in all facets of discovery optimization including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, and ultimately safety testing and IND submission, renders it particularly effective.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

    How Is the Pharma ADMET Testing Market Conceptually Defined?

    Pharma ADMET testing refers to a set of procedures and assays used in the pharmaceutical industry to assess the Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) of drug candidates. It is used for determining the safety and efficacy of potential drugs before they can be approved for clinical use.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12024

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Pharma ADMET Testing Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

    Pharma ADMET Testing Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Are the Primary Drivers Supporting the Market Growth of thePharma ADMET Testing Market?

    The pharma ADMET testing market is gaining traction due to an increase in product approvals. This term primarily involves the authorization process, where bodies like the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA) provide consent for a product to be sold and marketed. ADMET testing, which is vital for verifying the safety and effectiveness of innovative products, is compulsory for such regulatory approvals. For instance, it was reported by the National Library of Medicine, a national health professional resource and a biomedical library based in the U.S, that the FDA approved 55 new drugs in 2023, a substantial increase from 37 approvals in 2022. Thus, the escalating quantity of product approvals propels the growth of the pharma ADMET testing market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

    What is the Predicted Annual Growth Rate of thePharma ADMET Testing Market Impact Industry Trends by 2034?

    The market size for pharma ADMET testing has seen a significant increase in the past few years. It’s predicted to climb from $9.67 billion in 2024 to $10.73 billion in 2025, with a compound annual growth rate (CAGR) of 10.9%. The expansion in the historical period can be credited to factors such as the growth in the biopharmaceuticals and biosimilars industry, increased drugs development activities, rising awareness about drug safety, globalisation of clinical trials, and a shift towards in silico modeling.

    The market for ADMET testing in the pharmaceutical sector is predicted to experience substantial expansion in the upcoming years. By 2029, it is expected to reach a market size of $17.1 billion, with a CAGR of 12.4%. This projected growth can be associated with factors such as environmental toxicology, safety assessment, pharmacogenomics awareness, the shift towards precision medicine, the rise of biologics and biosimilars, the integration of AI, increased regulatory requirements, and the growth in development of orphan drugs. The forecast period will also witness major trends, including a boost in research partnerships, swift technological progress, advancements in analytical technologies, constant drug safety monitoring, and considerations regarding environmental impacts.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12024

    What Are the Latest Innovations Influencing thePharma ADMET Testing Market?

    A leading trend in the pharmaceutical ADMET testing market is the emergence of innovative products. Leading companies in the sector are developing pioneering products like Logica to maintain their competitiveness. For instance, Charles River Laboratories International Inc., a pharmaceutical company from the United States, and Valo Health Inc., a US-based AI-health solutions company, jointly launched an AI-based drug development solution, Logica, in April 2022. This latest solution exploits Valo’s AI-supported Opal Computational Platform to deliver ADMET testing services and other drug delivery frameworks. Logica employs the top-tier predictive models, chemical design and synthesis skills, DNA encoded libraries, and in silico high throughput screening available via Valo’s Opal Computational Platform, in conjunction with Charles River’s leading abilities in all areas of discovery optimization. This includes high throughput screening, medicinal chemistry, ADME, biology, pharmacology, and ultimately, safety testing and IND submission.

    Who Are the Major Industry Players Accelerating Growth in thePharma ADMET Testing Market?

    Major companies operating in the pharma ADMET testing market include Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

    Which Primary Segments of the Pharma ADMET Testing Market Are Driving Growth and Industry Transformations?

    The pharma ADMET testing market covered in this report is segmented –

    1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing

    2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology

    3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

    Subsegments:

    1) By In Vivo ADMET Testing: Animal Studies, Pharmacokinetics Studies, Toxicology Studies, Biodistribution Studies

    2) By In Vitro ADMET Testing: Metabolism Studies, Drug-Drug Interaction Studies, Absorption Studies, Cytotoxicity and Safety Testing

    3) By In Silico ADMET Testing: Predictive Modeling and Simulation, Quantitative Structure-Activity Relationship (QSAR) Analysis, Machine Learning Algorithms for ADMET Predictions, Software Tools for ADMET Profiling

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=12024&type=smp

    Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of thePharma ADMET Testing Market?# Market?

    Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Gobal Pharma ADMET Testing Maret 2025, By The Business Research Company:

    Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/services-global-market-report

    Testing, Inspection, And Certification Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/testing-inspection-and-certification-global-market-report

    Analytical Laboratory Instrument Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/analytical-laboratory-instrument-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Trends and Insights into the Pharma ADMET Testing Market: Growth Rate and Opportunities to 2034

    Key Trends and Insights into the Pharma ADMET Testing Market: Growth Rate and Opportunities to 2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What fueled the previous growth in the pharma admet testing market?

    In recent years, there has been rapid expansion in the size of the pharma ADMET testing market. The market is projected to grow from $9.67 billion in 2024 to $10.73 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.9%. The historical growth rate can be linked to the development of biopharmaceuticals and biosimilars, an increase in drug development activities, heightened awareness of drug safety, a worldwide diffusion of clinical trials, and a shift towards in silico modeling.

    What will be the pharma admet testing market size in the future?

    The projected market size for pharma ADMET testing is set to experience considerable rise in the coming years, expanding to a worth of $17.1 billion by 2029 with a compound annual growth rate (CAGR) of 12.4%. This progression in the predicted period is likely due to factors such as environmental toxicology, safety evaluation, the growing attention towards pharmacogenomics, emphasis on precision medicine, along with the expansion of biologics and biosimilars. It also involves the integration of artificial intelligence (AI), enhanced regulatory needs, and a surge in the development of orphan drugs. The forecast timeframe is also expected to see key trends like increased joint ventures in research, swift technological leaps, progression in analytical technologies, ongoing monitoring of drug safety, as well as considerations about environmental impact.

    Get your pharma admet testing market report here!

    https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

    What main drivers are fueling expansion in the pharma admet testing market?

    The escalation in the frequency of product authorizations serves as a propelling factor for the pharma ADMET testing market. These authorizations refer to the procedure in which regulatory bodies like the Food and Drug Administration (FDA) in the United States, or the European Medicines Agency (EMA) in Europe, provide the green light for a product to be sold and advertised to the public. ADMET testing enables the determination of the safety and effectiveness of new products and is compulsory in the regulatory approval of products. For instance, in January 2024, per the National Library of Medicine, a US-based biomedical library and a national resource center, it was stated that 55 new drugs were sanctioned by the U.S. Food and Drug Administration (FDA) in 2023, which is an increase from 37 drugs that were sanctioned in 2022. Hence, the acceleration in product authorizations impels the pharma ADMET testing market.

    What key areas define the segmentation of the global pharma admet testing market?

    The pharma ADMET testing market covered in this report is segmented –

    1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing

    2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology

    3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

    Subsegments:

    1) By In Vivo ADMET Testing: Animal Studies, Pharmacokinetics Studies, Toxicology Studies, Biodistribution Studies

    2) By In Vitro ADMET Testing: Metabolism Studies, Drug-Drug Interaction Studies, Absorption Studies, Cytotoxicity and Safety Testing

    3) By In Silico ADMET Testing: Predictive Modeling and Simulation, Quantitative Structure-Activity Relationship (QSAR) Analysis, Machine Learning Algorithms for ADMET Predictions, Software Tools for ADMET Profiling

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

    Who are the dominant players expanding their reach in the pharma admet testing market?

    Major companies operating in the pharma ADMET testing market include Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.

    How are evolving market trends shaping pharma admet testing Strategies?

    In the pharmaceutical ADMET testing market, product innovation is becoming a prominent trend. Major players in this market are releasing cutting-edge products like Logica to maintain their market dominance. For example, Charles River Laboratories International Inc., an American pharmaceutical company, and Valo Health Inc., an American AI-health solution firm, unveiled Logica, an AI-infused drug development tool, in April 2022. This innovative solution employs Valo’s AI-powered Opal Computational Platform to offer ADMET testing services and other drug delivery solutions. Logica takes advantage of top-tier predictive models, chemical design and synthesis capabilities, DNA coded libraries, and in silico high throughput screening from Valo’s Opal Computational Platform. This is on top of Charles River’s superior capabilities in all areas of discovery optimization including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, with an ultimate goal of safety testing and IND submission.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12024

    Which regions are emerging as leaders in the pharma admet testing market?

    Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/services-global-market-report

    Testing, Inspection, And Certification Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/testing-inspection-and-certification-global-market-report

    Analytical Laboratory Instrument Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/analytical-laboratory-instrument-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Pharma ADMET Testing Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know

    Pharma ADMET Testing Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Predicted CAGR for the Pharma ADMET Testing Market Over the Forecast Period of 2025 to 2034?

    The pharma ADMET testing market has seen rapid growth in recent years. It is expected to expand from $9.67 billion in 2024 to $10.73 billion in 2025, at a CAGR of 10.9%. The historical growth has been fueled by the rise of biopharmaceuticals and biosimilars, increasing drug development activities, heightened awareness of drug safety, the globalization of clinical trials, and the shift toward in silico modeling.

    The pharma ADMET testing market is anticipated to grow rapidly, reaching $17.1 billion by 2029 at a CAGR of 12.4%. This growth is fueled by advancements in environmental toxicology and safety assessments, rising awareness of pharmacogenomics, a stronger focus on precision medicine, the increasing development of biologics and biosimilars, AI integration, evolving regulatory requirements, and an increase in orphan drug development. Key trends in the forecast period include expanded research collaborations, rapid technological advancements, improvements in analytical technologies, continuous monitoring of drug safety, and considerations regarding environmental impact.

    What Drivers Are Shaping the Growth of the pharma admet testing Market?

    The increasing number of product approvals is expected to drive the growth of the pharma ADMET testing market. Product approvals are granted by regulatory authorities like the FDA or EMA, allowing products to be marketed. ADMET testing, used for assessing a product’s safety and efficacy, plays a vital role in these approvals. In 2023, the U.S. FDA approved 55 new drugs, a rise from 37 approvals in 2022. Therefore, the growing number of product approvals is driving the pharma ADMET testing market.

    Get Your Free Sample of the Global Pharma ADMET Testing Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

    Who Are the Top Companies Driving Innovation and Growth in the Pharma ADMET Testing Market?

    Major companies operating in the pharma ADMET testing market include:

    • Thermo Fisher Scientific Inc._x000D_

    • The Merck Group_x000D_

    • Laboratory Corporation of America Holdings_x000D_

    • IQVIA Inc._x000D_

    • PPD ICON plc_x000D_

    What Key Trends Are Currently Impacting the Pharma ADMET Testing Market’s Development?

    Product innovations are also gaining ground in the pharma ADMET testing market. Companies in this field are introducing new solutions like Logica to maintain their position. For example, in April 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company, in partnership with Valo Health Inc., a US-based AI-health solution provider, launched Logica, an AI-driven drug development solution. Logica utilizes Valo’s AI-powered Opal Computational Platform to offer ADMET testing services and other drug delivery solutions. The platform uses predictive models, chemical design, DNA encoded libraries, and in silico high-throughput screening to optimize drug development, including pharmacology and safety testing, ultimately supporting IND submission.

    Get Instant Access to the Global Pharma ADMET Testing Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

    What Are the Core Categories and Segments in the Pharma ADMET Testing Market Driving Demand and Growth?

    The pharma ADMET testing market covered in this report is segmented –

    1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing

    2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology

    3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

    Subsegments:

    1) By In Vivo ADMET Testing: Animal Studies, Pharmacokinetics Studies, Toxicology Studies, Biodistribution Studies

    2) By In Vitro ADMET Testing: Metabolism Studies, Drug-Drug Interaction Studies, Absorption Studies, Cytotoxicity and Safety Testing

    3) By In Silico ADMET Testing: Predictive Modeling and Simulation, Quantitative Structure-Activity Relationship (QSAR) Analysis, Machine Learning Algorithms for ADMET Predictions, Software Tools for ADMET Profiling

    Which Geographical Regions Are Pioneering Growth in the Pharma ADMET Testing Market?

    Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Key Characteristics That Define the Pharma ADMET Testing Market?

    Pharma ADMET testing refers to a set of procedures and assays used in the pharmaceutical industry to assess the Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) of drug candidates. It is used for determining the safety and efficacy of potential drugs before they can be approved for clinical use.

    Browse Through More Similar Reports By The Business Research Company:

    Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/services-global-market-report

    Testing, Inspection, And Certification Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/testing-inspection-and-certification-global-market-report

    Analytical Laboratory Instrument Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/analytical-laboratory-instrument-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Pharma ADMET Testing Market Key Insights 2024-2033: Growth Rate, Trends And Opportunities

    Pharma ADMET Testing Market Key Insights 2024-2033: Growth Rate, Trends And Opportunities

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Projected Growth Rate of the Pharma ADMET Testing Market from 2024 to 2033?

    The admet testing market within the pharmaceutical sector has experienced quick expansion in the last few years. Projected to launch from a value of $8.62 billion in 2023 and reach $9.61 billion in 2024, this market is expected to exhibit a compound annual growth rate (CAGR) of 11.5%. Factors contributing to the high growth rate during the historic period include the rise in biopharmaceuticals and biosimilars, an increase in drug development activities, better understanding of drug safety, the international expansion of clinical trials, and a move towards in silico modeling.

    The market size of pharma admet testing is projected to experience significant expansion in the coming years, with an estimated value of $14.87 billion in 2028, exhibiting a compound annual growth rate (CAGR) of 11.5%. Factors such as environmental toxicology and safety assessments, increased knowledge of pharmacogenomics, emphasis on precision medicine, expansion of biologics and biosimilars, use of artificial intelligence (AI), intensified regulatory requirements, and the rise in the development of orphan drugs are contributing to the forecasted growth. Trending patterns in the anticipated period include accelerated research collaborations, swift tech innovations, strides in analytical technologies, ongoing drug safety monitoring, and considerations of environmental impact.

    Claim Your Free Sample of the Global Pharma ADMET Testing Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

    What Are the Key Drivers of Growth in the pharma admet testing Market?

    The pharma ADMET testing market is being propelled by an increasing number of product approvals. These approvals are essentially the mechanisms through which regulatory bodies like the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA) gives the green light for a product to be offered and sold to consumers. It is crucial to do ADMET testing to ascertain the safety and effectiveness of new products and it is a compulsory task in the product regulatory approbation process. For example, data from the Center for Drug Evaluation and Research, a government agency in the US, reveals that 53 drugs were given approval in 2020; this is a rise compared to the 48 drugs given approval in 2019. Consequently, the growing quantity of product approvals is fuelling the pharma ADMET testing market.

    What Are the Notable Segments in the Pharma ADMET Testing Market?

    1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing

    2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology

    3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

    Which Emerging Trends Are Altering the Pharma ADMET Testing Market?

    The introduction of innovative products is the predominant trend emerging in the pharma ADMET testing market. Major players in this sector, such as Charles River Laboratories International Inc. and Valo Health Inc., are leveraging this trend to solidify their market dominance by launching revolutionary products like Logica. For instance, in April 2022, these US-based companies rolled out Logica, an AI-powered drug development tool. This innovative solution utilizes the Artificial Intelligence technology of Valo’s Opal Computational Platform to offer users ADMET testing services and various drug delivery solutions. Logica takes advantage of best-in-class predictive models, chemical design and synthesis capabilities, DNA-encoded libraries, and in silico high throughput screening from Valo’s Opal Computational Platform. Additionally, it utilizes Charles River’s top-tier capabilities in all areas of discovery optimization including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, safety testing, and ultimately IND submission.

    Order Now for Fast Delivery of Your Pharma ADMET Testing Market Report!

    https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

    Which Regions Are Most Influential in Expanding the Pharma ADMET Testing Market?

    Asia-Pacific was the largest region in the pharma ADMET testing market in 2023. The regions covered in the pharma admet testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Pharma ADMET Testing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the pharma admet testing market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Pharma ADMET Testing Market Include

    1. Pharma ADMET Testing Market Executive Summary

    2. Pharma ADMET Testing Market Segments

    3. Pharma ADMET Testing Market Size And Template Market Growth Rate

    4. Key Pharma ADMET Testing Market Trends

    5. Major Pharma ADMET Testing Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Pharma ADMET Testing Market

    26. Top Pharma ADMET Testing Companies

    27. Pharma ADMET Testing Market Opportunities And Strategies

    28. Pharma ADMET Testing Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Pharmacogenomics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

    Pharmacies and Healthcare Stores Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharmacies-and-healthcare-stores-global-market-report

    Temperature Controlled Pharmaceutical Containers Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/temperature-controlled-pharmaceutical-containers-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Growth Trajectory Of The Pharma ADMET Testing Market 2024-2033

    Growth Trajectory Of The Pharma ADMET Testing Market 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    The pharma ADMET testing market has experienced significant growth in recent years, with notable projections for the future. Here’s a breakdown of the key factors influencing this growth trajectory:

    Market Expansion in Recent Years

    • The market size surged from $8.62 billion in 2023 to $9.61 billion in 2024, exhibiting a compound annual growth rate (CAGR) of 11.5%.
    • Growth in the historic period is attributed to factors like the rise in biopharmaceuticals, increased drug development activities, and a global shift towards in silico modeling.

    Anticipated Growth by 2028

    • Forecasts indicate a further surge, with the market expected to reach $14.87 billion in 2028, maintaining the same CAGR of 11.5%.
    • The forecasted period will witness growth driven by environmental toxicology, emphasis on pharmacogenomics, and the burgeoning focus on precision medicine.

    Emerging Trends and Factors Shaping the Market

    • Collaborative research efforts are on the rise, leading to rapid technological innovations and advancements in analytical technologies.
    • Continuous monitoring of drug safety and environmental impact considerations are becoming integral aspects of ADMET testing processes.

    The Impact of Increasing Product Approvals

    • The rising number of product approvals is a significant driver for the pharma ADMET testing market.
    • Regulatory bodies like the FDA and EMA play crucial roles in granting approvals, necessitating thorough ADMET testing for product safety and efficacy.

    Key Players and Market Dynamics

    • Major companies driving the pharma ADMET testing market include Thermo Fisher Scientific Inc., Abbott Laboratories, and The Merck Group, among others.
    • These companies provide a range of ADMET testing services essential for regulatory compliance and product development.

    View More On The Pharma ADMET Testing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

    Product Innovations Driving Market Evolution

    • Product innovation is a prominent trend within the pharma ADMET testing market, with companies introducing cutting-edge solutions to stay competitive.
    • Notable innovations include Logica, an AI-based drug development solution launched by Charles River Laboratories International Inc. and Valo Health Inc.

    Market Expansion Through Acquisition

    • BioIVT’s acquisition of XenoTech underscores the market’s expansion strategies, aiming to broaden product portfolios and reach newer geographies.
    • XenoTech’s ADMET testing services complement BioIVT’s offerings, strengthening its position in the market.

    Segmentation and Regional Insights

    • The pharma ADMET testing market is segmented by testing type, technology, and application, catering to diverse industry needs.
    • Asia-Pacific emerged as the largest region in the pharma ADMET testing market in 2023, highlighting the global nature of this industry.

    Conclusion

    The pharma ADMET testing market is on a robust growth trajectory, fueled by a convergence of factors such as technological innovations, regulatory dynamics, and market expansion strategies. As the industry continues to evolve, stakeholders must remain agile to harness emerging opportunities and address evolving challenges effectively. With innovation at its core, the future of ADMET testing promises advancements that will redefine drug development processes and enhance patient outcomes on a global scale.

    Request A Sample Of The Global Pharma ADMET Testing Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12024&type=smp